WO2025229513 - PHARMACEUTICAL COMPOSITION OF RESMETIROM AND PROCESS THEREOF
National phase entry is expected:
Publication Number
WO/2025/229513
Publication Date
06.11.2025
International Application No.
PCT/IB2025/054426
International Filing Date
29.04.2025
Title **
[English]
PHARMACEUTICAL COMPOSITION OF RESMETIROM AND PROCESS THEREOF
[French]
COMPOSITION PHARMACEUTIQUE DE RESMÉTIROM ET SON PROCÉDÉ
Applicants **
MOREPEN LABORATORIES LIMITED
Inventors
CHATURVEDI, Kiran
SURI, Sanjay
Priority Data
202411034308
30.04.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1951 | |
| EPO | Filing, Examination, Granting | 11561 | |
| Japan | Filing, Examination, Granting | 2026 | |
| South Korea | Filing, Examination, Granting | 1765 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
23,243
Contact Us
Abstract[English]
The present invention relates to a solid, orally administrable pharmaceutical composition of resmetirom with one or more pharmaceutically acceptable excipients. More specifically a solid, orally administrable pharmaceutical composition may be prepared by a wet granulation process for preparing granules that are subsequently converted into solid oral dosage forms of resmetirom.[French]
La présente invention concerne une composition pharmaceutique solide administrable par voie orale de resmétirom avec un ou plusieurs excipients pharmaceutiquement acceptables. Plus spécifiquement, une composition pharmaceutique solide administrable par voie orale peut être préparée selon un procédé de granulation par voie humide pour préparer des granules qui sont ensuite convertis en formes posologiques orales solides de resmétirom.